Surg Endosc27 Oct 2023
Researchers delved into minimally invasive liver resections (MILR) and what happens when they switch to open procedures. Out of 1,675 patients, 6.1% required a switch due to unfavorable findings or intraoperative issues. Those needing a conversion experienced higher complications, blood loss, and mortality. Intraoperative conversions…
Am J Gastroenterol25 Oct 2023
Endoscopic findings reveal that post-COVID-19 cholangiopathy resembles secondary sclerosing cholangitis, affecting critically ill patients. It emerges early during intensive care, causing significant and often irreversible damage to bile ducts. Typical cholangiographic features include a centripetal pattern of bile duct destruction, "vanishing bile ducts," and intraductal…
World J Surg25 Oct 2023
Researchers investigated the impact of a weight-loss program (WLP) on patients with a high body mass index (BMI) before undergoing liver resection for hepatocellular carcinoma (HCC). In a study of 19 patients with a BMI of 25.0 or higher, WLP successfully led to weight loss…
J Surg Res25 Oct 2023
Researchers compared outcomes in patients with splenic pseudoaneurysms (PSAs) following blunt trauma, some treated with splenic artery embolization (Embo) and others without (No-Embo). Patients who underwent embolization had a significantly lower rate of failure of nonoperative management (FNOM) compared to the No-Embo group (3.1% vs.…
HPB (Oxford)25 Oct 2023
A multicentric survey involving 11 patients with liver tumors and 23 experienced surgeons demonstrated that 3D reconstructions significantly enhance the comprehension of complex liver anatomy and the relationship between tumors and adjacent vascular structures. Compared to standard 2D CT scans, the 3D models provided superior…
Ann Surg23 Oct 2023
This study examined whether administering neoadjuvant therapy (nat) followed by surgical resection is safe and effective in pancreatic ductal adenocarcinoma (PDAC) patients aged 75 and older. In a comprehensive three-part analysis, the research found that this aggressive treatment approach appears to be both safe and…
HPB & Spleen23 Oct 2023
Researchers have successfully validated the accuracy of two fistula risk scores, "distal fistula risk scores" and "dispair," in predicting postoperative pancreatic fistula (POPF) after distal pancreatectomy. These scores are based on various patient factors like body mass index, diabetes, and pancreatic characteristics. With a 19.3%…
World J Surg22 Oct 2023
Researchers compared treatments for common bile duct (CBD) stones, and ultrasound-guided percutaneous transhepatic cholangioscopic lithotripsy (PTCSL) stood out. PTCSL outperformed laparoscopic exploration, with better perioperative outcomes and fewer complications. It also beat endoscopic treatment with fewer instances of pancreatitis, reflux esophagitis, and papillary stenosis. Additionally,…
World J Surg22 Oct 2023
A systematic review and meta-analysis explored whether the presence of an aberrant right hepatic artery (A-RHA) influences outcomes after pancreaticoduodenectomy (PD). Results indicate that A-RHA doesn't significantly affect critical endpoints, such as tumor margin (R1) rate, overall survival, morbidity, mortality, and biliary fistula rate. Additionally,…
Ann Surg Oncol21 Oct 2023
Researchers compared the outcomes of liver-confined unresectable intrahepatic cholangiocarcinoma (ICCA) patients receiving systemic chemotherapy (gemcitabine and cisplatin) with those given hepatic arterial infusion pump (HAIP) chemotherapy. The study, involving 268 patients, revealed that HAIP chemotherapy significantly outperformed systemic treatment. Median survival for HAIP was 27.7…